Elicio Therapeutics, Inc.
ELTX
$4.80
$0.040.84%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -51.90M | -46.84M | -38.67M | -38.99M | -35.20M |
| Total Depreciation and Amortization | 1.18M | 1.16M | 1.14M | 1.35M | 1.17M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.69M | 8.82M | -256.00K | 3.11M | 1.39M |
| Change in Net Operating Assets | 3.96M | -1.36M | 1.65M | -2.14M | -57.00K |
| Cash from Operations | -37.07M | -38.22M | -36.13M | -36.68M | -32.69M |
| Capital Expenditure | -87.00K | -42.00K | -87.00K | -49.00K | -66.00K |
| Sale of Property, Plant, and Equipment | 3.00K | 3.00K | 3.00K | 37.00K | 34.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -84.00K | -39.00K | -84.00K | -12.00K | -32.00K |
| Total Debt Issued | 19.73M | 19.73M | 0.00 | 0.00 | 10.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 23.14M | 29.92M | 18.40M | 18.11M | 7.13M |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | -150.00K | -150.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -549.00K | -547.00K | 2.00K | 21.64M | 21.64M |
| Cash from Financing | 42.32M | 49.10M | 18.40M | 39.60M | 38.61M |
| Foreign Exchange rate Adjustments | 22.00K | -5.00K | -39.00K | 0.00 | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.19M | 10.83M | -17.85M | 2.91M | 5.89M |